If you have been reading about PPARδ agonist and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-07-26. Numbers and descriptions here follow the published literature rather than marketing material.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic PPARδ agonist | Not a steroid or a selective androgen receptor modulator. |
| Common synonyms | Cardarine, GW501516, GW-501516, endurobol | Names vary by supplier and literature source. |
| Appearance | White to off-white powder | Consistent with many small-molecule research chemicals. |
| Solubility | Low in water; soluble in DMSO and ethanol | Often prepared in organic solvent for laboratory work. |
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid and energy metabolism. |
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
== Chemistry == Protriptyline is a tricyclic compound, specifically a dibenzocycloheptadiene, and possesses three rings fused together with a side chain attached in its chemical structure. Other dibenzocycloheptadiene TCAs include amitriptyline, nortriptyline, and butriptyline. Protriptyline is a secondary amine TCA, with its N-methylated analog N–methylprotriptyline being a tertiary amine, and a structural isomer of amitriptyline. The tertiary amine analog of protriptyline, N–methylprotriptyline, has not been marketed. Other secondary amine TCAs include desipramine and nortriptyline. The chemical name of protriptyline is 3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine and its free base form has a chemical formula of C19H21N1 with a molecular weight of 263.377 g/mol. The drug is used commercially mostly as the hydrochloride salt; the free base form is not used. The CAS Registry Number of the free base is 438-60-8 and of the hydrochloride is 1225-55-4.
Sweden and Finland are furthest along in committing to a particular disposal technology, while many others reprocess spent fuel or contract with France or Great Britain to do it, taking back the resulting plutonium and high-level waste. "An increasing backlog of plutonium from reprocessing is developing in many countries... It is doubtful that reprocessing makes economic sense in the present environment of cheap uranium." In many European countries (e.g., Britain, Finland, the Netherlands, Sweden, and Switzerland) the risk or dose limit for a member of the public exposed to radiation from a future high-level nuclear waste facility is considerably more stringent than that suggested by the International Commission on Radiation Protection or proposed in the United States. European limits are often more stringent than the standard suggested in 1990 by the International Commission on Radiation Protection by a factor of 20, and more stringent by a factor of ten than the standard proposed by the U.S. Environmental Protection Agency (EPA) for the Yucca Mountain nuclear waste repository for the first 10,000 years after closure. The U.S. EPA's proposed standard for greater than 10,000 years is 250 times more permissive than the European limit. The U.S.
== GLP-1, GIP, and glucagon receptor triple agonists == Following the discovery of GLP-1/GIP and GLP-1/glucagon dual agonists, it was hoped that a triple agonist would provide additive or synergistic metabolic benefits. A clinical trial of the triple agonist retatrutide found an average 24.2% weight reduction in the highest dosage group after 24 weeks. Another clinical trial of triple agonist UBT-251 also found an average weight reduction of 19.7% after 24 weeks.
The rotation of plane polarized light by chiral substances was first observed by Jean-Baptiste Biot in 1812, and gained considerable importance in the sugar industry, analytical chemistry, and pharmaceuticals. Louis Pasteur deduced in 1848 that this phenomenon has a molecular basis. The term chirality itself was coined by Lord Kelvin in 1894. Individual enantiomers or diastereomers of a compound were formerly called optical isomers due to their distinct optical properties. At one time, chirality was thought to be restricted to organic chemistry, but this misconception was overthrown by the resolution of a purely inorganic compound, a cobalt complex called hexol, by Alfred Werner in 1911. In the early 1970s, various groups established that the human olfactory organ is capable of distinguishing chiral compounds.
glutamate (reduced nicotinamide adenine dinucleotide) synthase, glutamate synthase (NADH), L-glutamate synthetase(NADH), NADH-dependent glutamate synthase, NADH-glutamate synthase, and NADH-Glutamine oxoglutarate aminotransferase (NADH-GOGAT).
Sources: en.wikipedia.org
Manuel Antonio Noriega Moreno ( mahn-WEL NOR-ee-AY-gə; Spanish: [maˈnwel noˈɾjeɣa]; February 11, 1934 – May 29, 2017) was a Panamanian military officer and dictator who was the de facto ruler of Panama from 1983 to 1989. He never officially served as president of Panama, instead ruling as an unelected military dictator through puppet presidents. Amassing a personal fortune through drug trafficking operations by the Panamanian military, Noriega had longstanding ties with American intelligence agencies before the United States invasion of Panama removed him from power. Born in Panama City to a poor pardo family, Noriega studied at the Chorrillos Military School in Lima and at the School of the Americas. He became an officer in the Panamanian army, and rose through the ranks in alliance with Omar Torrijos. In 1968, Torrijos overthrew President Arnulfo Arias in a coup. Noriega became chief of military intelligence in Torrijos's government and, after Torrijos's death in 1981, consolidated power to become Panama's de facto ruler in 1983. Beginning in the 1950s, Noriega worked with U.S. intelligence agencies, and became one of the Central Intelligence Agency's most valued intelligence sources. He also served as a conduit for illicit weapons, military equipment, and cash destined for U.S.-backed forces throughout Latin America. Noriega's relationship with the U.S. deteriorated in the late 1980s after the murder of Hugo Spadafora and the forced resignation of President Nicolás Ardito Barletta.
== Biochemistry and effects == A wide variety of alkaloid and non-alkaloid compounds have been identified in various species of Ephedra. Of the six ephedrine-type ingredients found in ephedra (at concentrations of 0.02-3.4%), the most common are ephedrine and pseudoephedrine, which are the sources of its stimulant and thermogenic effects. These compounds stimulate the brain, increase heart rate, constrict blood vessels (increasing blood pressure), and expand bronchial tubes (making breathing easier). Their thermogenic properties cause an increase in metabolism, as evidenced by an increase in body heat. Ephedra is widely used by athletes as a performance-enhancing drug, despite a lack of evidence that it improves athletic performance. Ephedra may also be used as a precursor in the illicit manufacture of methamphetamine. Ephedra has been used as a weight-loss aid, sometimes in combination with aspirin and caffeine. Some studies in regulated and supervised environments have shown that ephedra is effective for marginal short-term weight loss (0.9 kg/month more than the placebo), although it was untested whether such weight loss is maintained. However, several reports have documented a number of adverse events attributable to unregulated ephedra supplements. Adverse effects of ephedra consumption may include severe skin reactions, irritability, nervousness, dizziness, trembling, headache, insomnia, profuse perspiration, dehydration, itchy scalp and skin, vomiting, and hyperthermia.
Steroid hormone receptors and related receptors are generally soluble proteins that function through gene activation. Lipid-soluble hormones target specific sequences of DNA by diffusing into the cell. When they have diffused into the cell, they bind to receptors (intracellular), and migrate into the nucleus. Their response elements are DNA sequences (promoters) that are bound by the complex of the steroid bound to its receptor. The receptors themselves are zinc-finger proteins. These receptors include those for glucocorticoids (glucocorticoid receptors), estrogens (estrogen receptors), androgens (androgen receptors), thyroid hormone (T3) (thyroid hormone receptors), calcitriol (the active form of vitamin D) (calcitriol receptors), and the retinoids (vitamin A) (retinoid receptors). Receptor-protein interactions induce the uptake and destruction of their respective hormones in order to regulate their concentration in the body. This is especially important for steroid hormones because many body systems are entirely steroid dependent.
(2026) report evidence of greater similarity of the vertebral apophyseal ring of Lucy (and likely spinal biomechanics of the studied individual) to those of extant African apes than to those of modern humans, and interpret this finding as indicative of emergence of fully modern human gait later in the hominin evolution. Hatala et al. (2026) describe approximately 1.43-million-years-old hominin footprints from northern Kenya produced by a group that included multiple adult males, preserving a morphology similar to footprints attributed to Paranthropus boisei, but produced by hominins larger than known representatives of that species. Evidence indicating that the evolution cranial morphological variation in members of the genus Homo was primarily influenced by selective constraints, their releases and by stabilizing selection rather than by gradual directional selection is presented by Hubbe & Harvati (2026). Blasi-Toccacceli et al. (2026) describe fossil material of a 1.84-million-years-old member of the genus Homo from the Shungura Formation (Ethiopia), including the oldest well-preserved shoulder and arm bones of a member of this genus, interpreted as indicative of reduction of use of arms in arboreal locomotion early in the evolution of Homo. The most complete skeleton of Homo habilis reported to date is described from the upper Burgi Member of the Koobi Fora Formation (Kenya) by Grine et al. (2026).
Importantly, an auricular hematoma can also occur on the posterior ear surface, or even both surfaces. Risk of necrotic tissue is greatest when both posterior and anterior surfaces are involved, although posterior surface involvement is less likely given its increased quantity of impact-dampening subcutaneous tissue.
Sources: en.wikipedia.org
where A = 0.02939 mPa·s, B = 507.88 K, and C = 149.3 K. Experimentally determined values of the viscosity are also given in the table below. The values at 20 °C are a useful reference: there, the dynamic viscosity is about 1 cP and the kinematic viscosity is about 1 cSt.
Transamination is mediated by several types of aminotransferase enzymes. An aminotransferase may be specific for an individual amino acid, or it may be able to process any member of a group of similar ones, for example the branched-chain amino acids, which comprises valine, isoleucine, and leucine. The two common types of aminotransferases are alanine aminotransferase (ALT) and aspartate aminotransferase (AST).
For asymptotically flat universes, Einstein and others salvage conservation of energy by introducing a specific global gravitational potential energy that cancels out mass-energy changes triggered by spacetime expansion or contraction. This global energy has no well-defined density and cannot technically be applied to a non-asymptotically flat universe; however, for practical purposes this can be finessed, and so by this view, energy is conserved in our universe. Alan Guth stated that the universe might be "the ultimate free lunch", and theorized that, when accounting for gravitational potential energy, the net energy of the Universe is zero.
(WINNER) The contestant won the whole competition. (WIN) The contestant won the Haunted Heat (HIGH) The contestant had one of the best dishes in the Haunted Heat. (IN) The contestant performed well enough to move on to the next week. ‡ The judges recognized this contestant for having the best dish in the Bake for Your Life challenge. (LOW) The contestant had one of the bottom dishes but was not eliminated. (OUT) The contestant was eliminated for worst dish.
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.
It binds to and activates PPARδ, a nuclear receptor that regulates genes related to fatty acid oxidation and energy use. This activation alters transcription in tissues such as skeletal muscle and liver. The full range of downstream effects in humans is not fully established.
No, cardarine is not known to occur naturally in plants, animals, or humans. It is a synthetic molecule produced for laboratory research. Products labeled as cardarine should therefore be treated as manufactured chemicals with variable purity.
Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.